The 2nd World Conference of Immuno-Oncology-2019 (WCIO-2019)

Conference Report

BIT's 2^nd World Conference of Immuno-Oncology-2019 (WCIO-2019) which was held in Dalian International Conference Center on Oct 11-13, achieved a consummation. Over 200 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are Dr. Kang Li, SVP, Head of Biologics, BeiGene, China; Dr. Seungpyo Hong, Professor, Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin - Madison, USA; Dr. Yi Jin, Senior Director of Research and Discovery, GenScript Biotech Corp., China; Dr. Qun Dang, Corporate Vice President, CSPC PHARMA LTD, China; Dr. Renfeng Guo, CSO and Founder, InflaRx Pharmaceuticals Inc., USA…etc.

This annual congress comprised of 15 sessions following the ceremony, including ''Emerging Target and Biomarker'', ''Precision Medicine"; ''IO Antibodies, Vaccines and Combination Immunotherapy''; ''Targeted Cancer Immunotherapy''…etc.

This annual conference brought together 200 specialists from 20 countries and areas, which was devoted to the leading issues and popular topics and provide up-to-date information to all over the world. In welcome banquet, all guests appreciated and joined in the brilliant Chinese traditional performances, also expressed sincerely congratulation to successful WCIO-2019. Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing WCIO-2020 which would be better and more successful. All of us are looking forward to meeting you again in 2020.

Program at a Glance

Stream 1	Plenary Keynote Forums & Special Events
Stream 2	Frontiers of Immuno-Oncology
Stream 3	Breaking Cancer Therapy

Keynote Speakers

	Dr. Kang Li, SVP, Head of Biologics, BeiGene, China		Dr. Yi Jin, Senior Director of Research and Discovery, GenScript Biotech Corp., China
	Dr. Qun Dang, Corporate Vice President, CSPC PHARMA LTD, China		Dr. Seungpyo Hong, Professor, University of Wisconsin - Madison, USA
	Dr. Renfeng Guo, CSO and Founder, InflaRx Pharmaceuticals Inc., USA

Confirmed Renowned Speakers

	Dr. Adel K. El-Naggar, Professor, The University of Texas MD Anderson Cancer Center, USA		Dr. Yinling Hu, Professor, National Cancer Institute, National Institutes of Health, USA
	Dr. Shikha Bose, Clinical Professor, Cedars-Sinai Medical Center & David Geffen School of Medicine, University of California, Los Angeles, USA		Dr. Jiann-Shiun Lai, Vice President, Development Center for Biotechnology, OBI Pharma, Inc., Taiwan
	Dr. Even Walseng, Staff Scientist, National Cancer Institute, National Institutes of Health, USA		Dr. Xiupeng Wang, Senior Researcher, National Institute of Advanced Industrial Science and Technology (AIST), Japan
	Dr. Joseph Aman, FAS Manager APAC, 10x Genomics, Inc, USA		Dr. Gaël Roué, Senior Scientist, Vall d'Hebron Institute of Oncology (VHIO), Spain
	Dr. Longqin Hu, Professor and Chair, Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, USA		Dr. Rong Shao, Professor, Department of General Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, China
	Dr. Kewal K. Jain, CEO, Jain PharmaBiotech, Switzerland		Dr. Pei Lin, Professor, University of Texas MD Anderson Cancer Center, USA
	Dr. Pranela Rameshwar, Professor of Medicine, Division of Hematology and Oncology, Rutgers New Jersey Medical School, USA		Dr. Philippe Bouvet, Professor, Cancer Research Center of Lyon, France

Introduction to Dalian

Dalian — the "Northern Pearl" and summer resort of China, compared to ancient capital cities such as Beijing, Xian, Nanjing or Xi’an, is a young city with only a 100-year history. Dalian is the most relaxed and livable city in Northeast China. In many parts of China, economic prosperity comes at the price of clean air and charm. Not so in Dalian, whose natural blessings are its biggest asset. Tree-lined, hilly streets, dotted colonial architectures, an impressive coastline with beaches, as well as its prosperous town, have made it being dubbed as the "Hong Kong of the North China". It is one of the three Best Tourism Cities (2006), along with Hangzhou and Chengdu, recognized by the National Tourism Administration.

News Release

● Call for Session Chairs, Speakers and Attendees
● Call for Collaborative Partners, Medias and Journals
● Speaking Proposals are Now being Accepted, Submit the Abstract Right Now
● REGISTER NOW to secure your attendance and enjoy favorable discount

Hosting Organization

Information Research Center of International Talent, State Administration of Foreign Experts Affairs, China

Operating Organization

BIT Group Global Ltd

Exhibitor

10x Genomics, Inc

Official Travel Agency

BIT World Travel Service, Inc.

BIT's Upcoming Events